Showing results (1-10 of 310) with videos related to
Sort By:
Pageof 31
European Journal of Pharmacology|October 24, 2002
Diacetylmorphine degradation to 6-monoacetylmorphine and morphine in cell culture: implications for in vitro studiesMark R Hutchinson, Andrew A SomogyiInternational Immunopharmacology|August 17, 2005
Characterisation of the in vitro modulation of splenocyte proliferation by non-4,5-epoxymorphinan opioidsMark R Hutchinson, Andrew A SomogyiEuropean Journal of Pharmacology|June 24, 2004
Relationship between 4,5-epoxymorphinan structure and in vitro modulation of cell proliferationMark R Hutchinson, Andrew A SomogyiInternational Immunopharmacology|September 8, 2004
(S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(--)-methadoneMark R Hutchinson, Andrew A SomogyiEuropean Journal of Clinical Pharmacology|October 30, 2008
Role of active metabolites in the use of opioidsJanet K Coller, Lona L Christrup, Andrew A SomogyiAddiction Biology|May 15, 2002
In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexoneSusan J Porter, Andrew A Somogyi, Jason M WhiteAddiction (Abingdon, England)|September 3, 2011
The effect of methadone on emotional reactivitySteven M Savvas, Andrew A Somogyi, Jason M WhiteAmerican Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 4, 2006
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatmentsDaniel T Barratt, Janet K Coller, Andrew A SomogyiAnaesthesia and Intensive Care|February 3, 2022
New pharmacological perspectives and therapeutic options for opioids: Differences matterAndrew A Somogyi, Stefan T Musolino, Daniel T BarrattPharmacological Research|December 14, 2016
Advances in drug metabolism and pharmacogenetics research in AustraliaPeter I Mackenzie, Andrew A Somogyi, John O MinersPageof 31